FARMERS BRANCH, Texas, May 30, 2013 /PRNewswire/ -- CCS Medical (a.k.a. DEGC Enterprises [U.S.], Inc.), a leading provider of home delivery medical equipment and supplies, has announced the enhanced product formulary it will be using as a winner in Medicare's National Competitive Bidding Program for mail order diabetic testing supplies.
Effective July 1, CCS Medical will be one of only 18 Medicare mail order suppliers providing diabetic testing supplies nationwide. The company will be providing patients with industry leader LifeScan's OneTouch® products, the No. 1 brand recommended by endocrinologists and diabetes educators. Other major name brands offered by CCS Medical include Nipro, Prodigy, and GE. A complete list of the enhanced product formulary is located on the CCS Medical website at www.ccsmed.com/products.aspx.
Zeke Zoccoli, Executive Vice President & Chief Operating Officer, emphasized CCS Medical's commitment to its mission of providing low-cost, high-quality products to improve patients' lives. Zoccoli stated, "We are offering these products because they align with our mission statement. Through our strong vendor partnerships, we stand ready to serve new and existing patients across the country by providing them the highest quality products delivered directly to their homes at an affordable price."
About CCS Medical
Established in 1994, CCS Medical is a rapidly growing provider of low-cost, high-quality products and services delivered directly to homes of patients with chronic conditions. The company offers a single source solution for diabetic testing supplies, insulin pumps, advanced wound care dressings, catheters, ostomy and incontinence supplies, and prescription medications. CCS Medical's patient-centered model specializes in convenient home delivery, product education, and insurance processing. CCS Medical is a privately held company. More information is available at www.ccsmed.com.
SOURCE CCS Medical